{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:44:00Z","timestamp":1784735040183,"version":"3.55.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Miao Kourong","award":["81470329"],"award-info":[{"award-number":["81470329"]}]},{"name":"Miao Kourong","award":["81470329"],"award-info":[{"award-number":["81470329"]}]},{"name":"Miao Kourong","award":["81470329"],"award-info":[{"award-number":["81470329"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00277-024-05714-y","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T02:08:35Z","timestamp":1711937315000},"page":"1775-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report"],"prefix":"10.1007","volume":"103","author":[{"given":"Jiawen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"issue":"4","key":"5714_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N, Hirokawa M (2008) Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142(4):505\u2013514","journal-title":"Br J Haematol"},{"issue":"4","key":"5714_CR2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/bjh.17463","volume":"193","author":"T Longval","year":"2021","unstructured":"Longval T et al (2021) Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study. Br J Haematol 193(4):814\u2013826","journal-title":"Br J Haematol"},{"issue":"1","key":"5714_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000337022","volume":"5","author":"SH Jung","year":"2012","unstructured":"Jung SH et al (2012) Successful treatment of pure red cell aplasia with Rituximab in patients after ABO-Compatible allogeneic hematopoietic stem cell transplantation. Case Rep Oncol 5(1):110\u2013113","journal-title":"Case Rep Oncol"},{"issue":"2","key":"5714_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ejh.13343","volume":"104","author":"MQ Salas","year":"2020","unstructured":"Salas MQ, Alahmari A, Lipton JH (2020) Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab. Eur J Haematol 104(2):145\u2013147","journal-title":"Eur J Haematol"},{"issue":"4","key":"5714_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41409-020-01124-6","volume":"56","author":"J Marco-Ayala","year":"2021","unstructured":"Marco-Ayala J et al (2021) Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question. Bone Marrow Transpl 56(4):769\u2013778","journal-title":"Bone Marrow Transpl"},{"issue":"19","key":"5714_CR6","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJMoa1807438","volume":"379","author":"CI Chapuy","year":"2018","unstructured":"Chapuy CI et al (2018) Daratumumab for delayed red-cell engraftment after allogeneic transplantation. N Engl J Med 379(19):1846\u20131850","journal-title":"N Engl J Med"},{"issue":"3","key":"5714_CR7","first-page":"471","volume":"16","author":"DF Roychowdhury","year":"1995","unstructured":"Roychowdhury DF, Linker CA (1995) Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transpl 16(3):471\u2013472","journal-title":"Bone Marrow Transpl"},{"issue":"12","key":"5714_CR8","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2003-05-1738","volume":"102","author":"Y Saunthararajah","year":"2003","unstructured":"Saunthararajah Y et al (2003) Effects of 5-aza-2\u2019-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 102(12):3865\u20133870","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05714-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05714-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05714-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:05:26Z","timestamp":1712901926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05714-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["5714"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05714-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for the publication of any potentially identifable data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}